Abstract 1527 Table 1

Responses to questions 3, 5, 7 and 9 of survey

Question 3. Would you consider thromboprophylaxis with the following? (116 responses) Number (%)
Above knee Plaster of Paris or resin cast 114 (98)
Below knee Plaster of Paris or resin cast 110 (95)
Below knee Equinus Plaster of Paris or Resin Cast 110 (95)
Walking boot 61 (53)
Removable knee splint 23 (20)
No immobilisation, but crutches and weight bearing as tolerated 6 (5)
Question 5. What Risk Assessment Method do you use? (102 responses) Number (%)
Locally developed tool (unpublished) 32 (31)
NICE guidelines 26 (25)
I do not know which one we use 23 (22)
GEMNet 7 (7)
Plymouth Score 7 (7)
L-TRiP(cast) Score 1 (1)
TRiP(cast) Score 3. Would you consider thromboprophylaxis with the following? 1 (1)
Modified Caprini Score 0 (0)
Other 6 (6)
Question 7. What Thromboprophylaxis agent is first line recommended at your institution? (112 responses) Number (%)
Low Molecular Weight Heparin 78 (70)
Enoxaparin 42 (38)
Dalteparin 26 (23)
Tinzaparin 10 (9)
Direct Oral Anticoagulant 33 (29)
Rivaroxaban 27 (24)
Apixaban 6 (5)
Aspirin 1 (1)
Question 9. Which projects would your ED be willing to engage in? (109 responses) Number (%)
A comparison of different Risk Assessment Models (RAMs) 66 (61)
A comparison of DOACs vs LMWH in all patients 66 (61)
A comparison of DOACs vs LMWH for selected patients at higher risk of VTE 55 (51)
An observational study of those not receiving VTE prophylaxis to determine modern event rates 46 (42)
A mixed methods study evaluating multiple objectives as above 45 (41)